Comerica Bank Blueprint Medicines Corp Transaction History

Comerica Bank

$25 Billion
Q3 2024

A detailed history of Comerica Bank transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Comerica Bank holds 2,564 shares of BPMC stock, worth $243,836. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,564

Previous 15,664 83.63%

Holding current value

$243,836

Previous $1.69 Million 85.96%

% of portfolio

0.0%

Previous 0.01%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$84.1 - $120.5 $1.1 Million - $1.58 Million	-13,100 Reduced 83.63%	2,564 $237,000
Q2 2024 Aug 15, 2024	BUY	$85.18 - $108.78 $410,993 - $524,863	4,825 Added 44.52%	15,664 $1.69 Million
Q1 2024 May 15, 2024	BUY	$73.17 - $99.79 $763,528 - $1.04 Million	10,435 Added 2582.92%	10,839 $1.03 Million
Q4 2023 Feb 14, 2024	BUY	$43.96 - $92.84 $43 - $92	1 Added 0.25%	404 $37,000
Q3 2023 Nov 21, 2023	BUY	$46.9 - $66.0 $18,900 - $26,598	403 New	403 $20,000
Q4 2022 Jan 26, 2023	BUY	$41.06 - $66.48 $262,209 - $424,541	6,386 Added 8.79%	79,000 $0
Q3 2022 Oct 28, 2022	SELL	$49.93 - $77.7 $2.69 Million - $4.18 Million	-53,860 Reduced 42.59%	72,614 $3.52 Million
Q2 2022 Aug 02, 2022	BUY	$45.23 - $70.15 $788,132 - $1.22 Million	17,425 Added 15.98%	126,474 $7.02 Million
Q1 2022 Apr 27, 2022	BUY	$54.1 - $110.08 $699,350 - $1.42 Million	12,927 Added 13.45%	109,049 $6.97 Million
Q4 2021 Feb 18, 2022	SELL	$94.25 - $115.99 $175,305 - $215,741	-1,860 Reduced 1.9%	96,122 $10.3 Million
Q3 2021 Nov 22, 2021	SELL	$80.98 - $109.47 $390,080 - $527,316	-4,817 Reduced 4.69%	97,982 $10.1 Million
Q2 2021 Aug 26, 2021	BUY	$82.78 - $101.0 $2.71 Million - $3.3 Million	32,720 Added 46.69%	102,799 $9.04 Million
Q1 2021 Apr 28, 2021	BUY	$90.71 - $108.28 $3.6 Million - $4.3 Million	39,686 Added 130.58%	70,079 $6.81 Million
Q4 2020 Jan 28, 2021	BUY	$92.08 - $124.48 $1.06 Million - $1.43 Million	11,514 Added 60.99%	30,393 $3.41 Million
Q3 2020 Oct 30, 2020	BUY	$66.45 - $92.7 $296,167 - $413,163	4,457 Added 30.9%	18,879 $1.75 Million
Q2 2020 Jul 31, 2020	SELL	$57.09 - $79.27 $148,947 - $206,815	-2,609 Reduced 15.32%	14,422 $1.12 Million
Q1 2020 May 01, 2020	BUY	$48.11 - $82.22 $150,488 - $257,184	3,128 Added 22.5%	17,031 $995,000
Q4 2019 Feb 07, 2020	SELL	$66.73 - $82.59 $202,125 - $250,165	-3,029 Reduced 17.89%	13,903 $1.11 Million
Q3 2019 Oct 31, 2019	BUY	$72.9 - $101.41 $434,556 - $604,505	5,961 Added 54.33%	16,932 $1.24 Million
Q2 2019 Aug 02, 2019	BUY	$73.54 - $97.8 $188,188 - $250,270	2,559 Added 30.42%	10,971 $0
Q1 2019 May 02, 2019	SELL	$48.7 - $86.6 $204,783 - $364,153	-4,205 Reduced 33.33%	8,412 $0
Q4 2018 Feb 06, 2019	BUY	$45.57 - $74.26 $99,342 - $161,886	2,180 Added 20.89%	12,617 $878,000
Q3 2018 Nov 01, 2018	BUY	$58.91 - $78.32 $614,843 - $817,425	10,437 New	10,437 $729,000

Others Institutions Holding BPMC

# of Institutions

352

Shares Held

60.3M

Call Options Held

2.25M

Put Options Held

1.18M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.68B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Comerica Bank, based on Form 13F filings with the SEC.

News

Stay updated on Comerica Bank with notifications on news.

Account